Effectiveness of the Telemedical Lifestyle Intervention Program TeLIPro for Improvement of HbA

HbA1c cardiovascular risk factors health insurance lifestyle intervention type 2 diabetes weight loss

Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
12 Sep 2023
Historique:
received: 17 08 2023
revised: 04 09 2023
accepted: 08 09 2023
medline: 29 9 2023
pubmed: 28 9 2023
entrez: 28 9 2023
Statut: epublish

Résumé

The effectiveness of the multimodal Telemedical Lifestyle Intervention Program (TeLIPro) was proven in the advanced stages of type 2 diabetes mellitus (T2DM). Since its therapeutic potential focusing on telemedical coaching without using a formula diet is unknown, we evaluated improvements in HbA

Identifiants

pubmed: 37764738
pii: nu15183954
doi: 10.3390/nu15183954
pmc: PMC10534832
pii:
doi:

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Innovation Funds of the German Federal Ministry of Health
ID : 01NVF17033

Références

J Psychosom Res. 1985;29(1):71-83
pubmed: 3981480
World J Diabetes. 2021 Feb 15;12(2):170-197
pubmed: 33594336
Diabetes Care. 2018 May;41(5):971-978
pubmed: 29348194
Diabetes Care. 2016 Nov;39(11):2089-2095
pubmed: 27926892
J Telemed Telecare. 2022 Dec;28(10):764-770
pubmed: 36346936
J Acad Nutr Diet. 2015 Sep;115(9):1447-63
pubmed: 25935570
Diabetes Care. 2022 Mar 21;:
pubmed: 35312758
Nutrients. 2022 Jul 30;14(15):
pubmed: 35956337
Diabetes Care. 2011 Jan;34(1):14-9
pubmed: 20929998
Exp Clin Endocrinol Diabetes. 2022 Sep;130(S 01):S151-S184
pubmed: 35359013
Ann Intern Med. 2007 Jul 3;147(1):41-50
pubmed: 17606960
J Clin Epidemiol. 1998 Nov;51(11):1171-8
pubmed: 9817135
JMIR Mhealth Uhealth. 2020 Jul 8;8(7):e17842
pubmed: 32459631
Nat Commun. 2021 Sep 10;12(1):5367
pubmed: 34508090
Nutrients. 2022 Aug 19;14(16):
pubmed: 36014930
Med Care. 2009 Jun;47(6):626-33
pubmed: 19433995
Nutrients. 2018 Aug 04;10(8):
pubmed: 30081574
BMC Public Health. 2023 Jan 13;23(1):95
pubmed: 36639632
Diabetes Care. 2019 Jan;42(Suppl 1):S46-S60
pubmed: 30559231
Diabetologia. 2022 Jan;65(1):14-36
pubmed: 34796367
Pharmacoecon Open. 2023 Mar;7(2):163-173
pubmed: 36495462
Eur J Nutr. 2020 Jun;59(4):1313-1328
pubmed: 31781857
Clin Chim Acta. 2013 Mar 15;418:63-71
pubmed: 23318564
Lancet Diabetes Endocrinol. 2019 May;7(5):344-355
pubmed: 30852132
Diabetologia. 2011 Oct;54(10):2506-14
pubmed: 21656330
N Engl J Med. 2018 Jun 21;378(25):e34
pubmed: 29897866
Lancet. 2017 Nov 4;390(10107):2050-2062
pubmed: 28864332
Diabetes Care. 2006 Sep;29(9):2137-9
pubmed: 16936168
Am J Prev Med. 2022 Apr;62(4):567-577
pubmed: 35151522
Diabet Med. 2019 Oct;36(10):1217-1225
pubmed: 30659656
Nutrients. 2020 Jul 07;12(7):
pubmed: 32646010
J Med Internet Res. 2018 May 04;20(5):e162
pubmed: 29728346
Front Endocrinol (Lausanne). 2022 Mar 15;13:848695
pubmed: 35370974
Int J Behav Nutr Phys Act. 2017 Feb 8;14(1):18
pubmed: 28178985
Diabetes Care. 2017 Jul;40(7):863-871
pubmed: 28500214
J Diabetes Sci Technol. 2023 May;17(3):794-825
pubmed: 34957864
Diabetes Care. 2021 Aug 30;:
pubmed: 34462270
Diabetes Care. 2014 Dec;37(12):3317-24
pubmed: 25315207
Lancet Diabetes Endocrinol. 2020 Jun;8(6):477-489
pubmed: 32445735

Auteurs

Kerstin Kempf (K)

West-German Centre of Diabetes and Health, Düsseldorf Catholic Hospital Group, 40591 Düsseldorf, Germany.

Clara Dubois (C)

inav-Private Institute for Applied Health Services Research GmbH, 10117 Berlin, Germany.

Matthias Arnold (M)

inav-Private Institute for Applied Health Services Research GmbH, 10117 Berlin, Germany.

Volker Amelung (V)

inav-Private Institute for Applied Health Services Research GmbH, 10117 Berlin, Germany.

Nora Leppert (N)

German Institute for Telemedicine and Healthcare (DITG) GmbH, 40591 Düsseldorf, Germany.

Sibel Altin (S)

General Health Insurance Scheme (AOK Rheinland/Hamburg-Die Gesundheitskasse), 40213 Düsseldorf, Germany.

Markus Vomhof (M)

Institute for Health Services Research and Health Economics, German Diabetes Center, Leibniz Center for Diabetes Research at the Heinrich-Heine-University Düsseldorf, 40225 Düsseldorf, Germany.
Institute for Health Services Research and Health Economics, Centre for Health and Society, Faculty of Medicine, Heinrich-Heine-University Düsseldorf, 40225 Düsseldorf, Germany.
German Center for Diabetes Research (DZD), 85764 Neuherberg, Germany.

Andrea Icks (A)

Institute for Health Services Research and Health Economics, German Diabetes Center, Leibniz Center for Diabetes Research at the Heinrich-Heine-University Düsseldorf, 40225 Düsseldorf, Germany.
Institute for Health Services Research and Health Economics, Centre for Health and Society, Faculty of Medicine, Heinrich-Heine-University Düsseldorf, 40225 Düsseldorf, Germany.
German Center for Diabetes Research (DZD), 85764 Neuherberg, Germany.

Stephan Martin (S)

West-German Centre of Diabetes and Health, Düsseldorf Catholic Hospital Group, 40591 Düsseldorf, Germany.
Faculty of Medicine, Heinrich-Heine-University Düsseldorf, 40225 Düsseldorf, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH